Related Experiment Video
Updated: Jun 27, 2025

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
[Research progress on bioinformatics in pulmonary arterial hypertension]
Wei Peng1, Ze-Ying Zhang, Yun-Bin Xiao1
1School of Pediatrics, University of South China, Changsha 410007, China.
Bioinformatics, using tools like AI and multi-omics, advances understanding of pulmonary arterial hypertension (PAH) pathogenesis. This review explores bioinformatics applications in PAH research, diagnosis, and prognosis, highlighting future potential.
Area of Science:
- Cardiovascular Research
- Genomics and Bioinformatics
- Pulmonary Medicine
Background:
- Pulmonary arterial hypertension (PAH) involves complex vascular remodeling and elevated right ventricular pressure, significantly impacting patient health.
- Despite progress, the deeper pathogenic mechanisms of PAH require further elucidation.
- Bioinformatics offers advanced tools for dissecting complex diseases like PAH.
Purpose of the Study:
- To review bioinformatics methods and technologies applied to pulmonary arterial hypertension (PAH) research.
- To summarize current applications of bioinformatics in understanding PAH mechanisms, diagnosis, and prognosis.
- To analyze challenges and future potential of bioinformatics in PAH clinical and basic research.
Main Methods:
- Review of current literature on bioinformatics applications in PAH.
- Integration of multi-omics analysis, artificial intelligence, and Mendelian randomization techniques.
- Analysis of bioinformatics tools for disease mechanism, diagnosis, and prognosis assessment.
Main Results:
- Bioinformatics provides powerful approaches for understanding complex PAH mechanisms.
- Current applications span disease mechanism elucidation, diagnostic improvements, and prognostic assessments.
- Identified challenges and future opportunities for bioinformatics in PAH research.
Conclusions:
- Bioinformatics is crucial for unraveling the intricate pathogenesis of pulmonary arterial hypertension (PAH).
- Continued development and application of bioinformatics tools will enhance PAH diagnosis and prognosis.
- Future research should focus on overcoming current challenges to fully leverage bioinformatics in PAH clinical and basic science.
More Related Videos
10:20Right Ventricular Systolic Pressure Measurements in Combination with Harvest of Lung and Immune Tissue Samples in Mice
Published on: January 16, 2013
07:11Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis
Published on: May 23, 2025
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...